Innovation in Clinical Research: AI-Based Drug Development Tools and The Regulatory Landscape [Video]

December 2, 2021 | Utilizing new technology is crucial for accelerating advancements in clinical research. Novel drug development tools must undergo regulatory scrutiny to ensure their validity and safety. An example of an AI-based drug development tool is a digital twin—an AI-generated placebo outcome derived from patient baseline data in clinical trials. Digital twins can be used in trials to offer insights at the patient level—facilitating smaller, more efficient trials. We are actively collaborating with regulators, industry experts, and drug sponsors to chart a strategic path toward regulatory clarity for innovative drug development tools like digital twins. Listen to our founder and CEO, Charles Fisher, along with other industry regulatory experts, as they discuss the current regulatory landscape and how innovators can influence the future of AI’s use and regulation in drug development.